These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 17359700)
1. [Study on sensitivity to chemotherapy by combination therapy with tumor necrosis factor-alpha and bromocriptine in the multidrug resistant subcell line of HepG2]. Ding L; Chen XP; Zhang ZW; Jing K; Cao B; Zhu P; Li J; Zhang DY Zhonghua Wai Ke Za Zhi; 2006 Dec; 44(23):1644-7. PubMed ID: 17359700 [TBL] [Abstract][Full Text] [Related]
2. [Synergistic effect of bromocriptine combining tumor necrosis factor-alpha on reversing multidrug resistance in a nude mouse model of liver neoplasm]. Ding L; Chen XP; Zhang ZW; Wang H; Cao B; Wang ZH; Li CL Zhonghua Wai Ke Za Zhi; 2005 Oct; 43(19):1248-53. PubMed ID: 16271222 [TBL] [Abstract][Full Text] [Related]
3. [Study on the mechanism of reversing multidrug resistance of hepatocarcinoma by bromocriptine]. Ding L; Chen XP; Zhang ZW; Zhang WG; Cao B; Wang ZH; Li CL Zhonghua Gan Zang Bing Za Zhi; 2006 May; 14(5):353-7. PubMed ID: 16732910 [TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of bromocriptine and tumor necrosis factor-alpha on reversing hepatocellular carcinoma multidrug resistance in nude mouse MDR1 model of liver neoplasm. Ding L; Chen XP; Zhang ZW; Guan J; Zhang WG; Wang HP; Wang ZH; Li CL World J Gastroenterol; 2005 Sep; 11(36):5621-6. PubMed ID: 16237754 [TBL] [Abstract][Full Text] [Related]
5. [TNF-alpha induced reversal of multidrug resistance in human hepatocellular carcinoma cells]. Wang Q; Chen XP; Hai S; Li GP; Guan J; Zhang BX; Zhang WG Zhonghua Wai Ke Za Zhi; 2007 May; 45(9):602-4. PubMed ID: 17688793 [TBL] [Abstract][Full Text] [Related]
6. Ultrasound reverses multidrug resistance in human cancer cells by altering gene expression of ABC transporter proteins and Bax protein. Wu F; Shao ZY; Zhai BJ; Zhao CL; Shen DM Ultrasound Med Biol; 2011 Jan; 37(1):151-9. PubMed ID: 21084157 [TBL] [Abstract][Full Text] [Related]
7. [Reversion of drug-resistant hepatocellular carcinoma cell line BEL-7402/FU by sorafenib]. Wei L; Su N; Zheng DY; Cao MR; Li AM; Yan X; Lü CW; Luo RC Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Apr; 25(4):344-7. PubMed ID: 19351508 [TBL] [Abstract][Full Text] [Related]
8. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1. Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188 [TBL] [Abstract][Full Text] [Related]
9. Development and characterization of multidrug resistant human hepatocarcinoma cell line in nude mice. Zhai BJ; Shao ZY; Zhao CL; Hu K; Wu F World J Gastroenterol; 2006 Nov; 12(41):6614-9. PubMed ID: 17075973 [TBL] [Abstract][Full Text] [Related]
10. [Establishment of human multidrug-resistant hepatocellular carcinoma cell line (HepG2/Adm) and biological characteristics evaluation]. Zhai BJ; Wu F; Shao ZY; Hu K; Wang ZB Ai Zheng; 2004 Apr; 23(4):391-5. PubMed ID: 15087025 [TBL] [Abstract][Full Text] [Related]
11. Reversing multidrug-resistant by RNA interference through silencing MDR1 gene in human hepatocellular carcinoma cells subline Bel-7402/ADM. Sheng L; Xiong M; Li C; Meng X Pathol Oncol Res; 2014 Jul; 20(3):541-8. PubMed ID: 24327315 [TBL] [Abstract][Full Text] [Related]
12. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells. Li B; Ye T; Zhao L; Li DH; Gou XH; Zhao LY; Han L; Chen L; Yan LN; Gong JP Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):552-9. PubMed ID: 17085341 [TBL] [Abstract][Full Text] [Related]
13. [Intercellular transfer of P-glycoprotein in hepatocellular cell line HepG2]. Chen L; Zuo GQ; Wu JF; Zeng GL; Li T; Liu ZJ; Tang KF Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):839-42. PubMed ID: 19958644 [TBL] [Abstract][Full Text] [Related]
14. [Suppression of MDR1 expression and restoration of sensitivity to chemotherapy in multidrug-resistant hepatocellular carcinoma cell line Bel7402/5-Fu by RNA interference]. Ren YY Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Dec; 31(6):872-6. PubMed ID: 17213586 [TBL] [Abstract][Full Text] [Related]
15. [Impact of epigallocatechin gallate on gene expression profiles of human hepatocellular carcinoma cell lines BEL7404/ADM and BEL7402/5-FU]. Tang HH; Zhou M; Liang G Ai Zheng; 2008 Oct; 27(10):1056-64. PubMed ID: 18851785 [TBL] [Abstract][Full Text] [Related]
16. Role and mechanisms of microRNA‑503 in drug resistance reversal in HepG2/ADM human hepatocellular carcinoma cells. Wang D; Zhang N; Ye Y; Qian J; Zhu Y; Wang C Mol Med Rep; 2014 Dec; 10(6):3268-74. PubMed ID: 25269574 [TBL] [Abstract][Full Text] [Related]
17. [Reversal of multidrug resistance of human hepatocellular carcinoma cells by wild-type p53 gene and related mechanisms]. Gai XD; Li GL; Huang JZ; Xue HJ; Wang D Ai Zheng; 2006 Aug; 25(8):954-9. PubMed ID: 16965674 [TBL] [Abstract][Full Text] [Related]
18. Synergism of hydroxyapatite nanoparticles and recombinant mutant human tumour necrosis factor-alpha in chemotherapy of multidrug-resistant hepatocellular carcinoma. Li G; Dong S; Qu J; Sun Z; Huang Z; Ye L; Liang H; Ai X; Zhang W; Chen X Liver Int; 2010 Apr; 30(4):585-92. PubMed ID: 19780956 [TBL] [Abstract][Full Text] [Related]
19. [In vivo reversal of multidrug resistance by transduction of human tumor necrosis factor-alpha into drug resistant cell line of choriocarcinoma]. Feng FZ; Xiang Y; Cui ZM; Liu ZH; Yang XY Zhonghua Fu Chan Ke Za Zhi; 2003 May; 38(5):294-7. PubMed ID: 12895315 [TBL] [Abstract][Full Text] [Related]
20. [Significance and reversal of MDR1/P-gp in pancreatic cancer chemotherapy]. Guo JC; Zhao YP; Liao Q; Zhu Y Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(21):1488-90. PubMed ID: 18275717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]